Mostrar el registro sencillo del ítem
Factors Associated with Drug Consumption Without Scientific Evidence in Patients with Mild COVID-19 in Peru.
| dc.contributor.author | Soriano-Moreno, D.R. | es_PE |
| dc.contributor.author | Fernandez-Guzman, D. | es_PE |
| dc.contributor.author | Sangster-Carrasco, L. | es_PE |
| dc.contributor.author | Quispe-Vicuña, C. | es_PE |
| dc.contributor.author | Grados-Espinoza, P. | es_PE |
| dc.contributor.author | Ccami-Bernal, F. | es_PE |
| dc.contributor.author | Morocho-Alburqueque, N. | es_PE |
| dc.contributor.author | Coba-Villan, N. | es_PE |
| dc.contributor.author | Velasquez-Fernandez, R. | es_PE |
| dc.contributor.author | Nieto- Gutierrez, W. | es_PE |
| dc.date.accessioned | 2026-02-07T14:54:44Z | |
| dc.date.available | 2026-02-07T14:54:44Z | |
| dc.date.issued | 2022 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.14074/9521 | |
| dc.description.abstract | Objective This study aimed to evaluate the factors associated with the consumption of drugs without scientific evidence in patients with mild COVID-19 infection in Peru. Methods An analytical cross-sectional study was carried out including 372 adult patients with a history of mild COVID-19 disease. Factors associated with drug consumption were evaluated by Poisson regressions with robust variance adjustment using the bootstrapping resampling method. Results Seventy-two percent consumed some medication without scientific evidence, with antibiotics (71%) and ivermectin for human use (68%) being the most commonly used. Factors associated with the consumption of drugs to treat mild COVID-19 infection were thinking that the drugs are not effective (adjusted prevalence ratio, 0.55; 95% confidence interval, 0.41-0.74) and not being informed about the efficacy of the drugs (adjusted prevalence ratio, 0.48; 95% confidence interval, 0.36-0.65). Conclusions Education of the population seems to be the main factor that increases the consumption of drugs without scientific evidence in the Peruvian population to treat mild COVID-19. | es_PE |
| dc.format | application/pdf | es_PE |
| dc.language.iso | eng | es_PE |
| dc.publisher | Lippincott Williams and Wilkins. | es_PE |
| dc.relation.ispartof | J Patient Saf 2022;18: e1189–e1195 | es_PE |
| dc.relation.ispartof | urn:issn:15498417 | es_PE |
| dc.relation.ispartof | https://www.scopus.com/pages/publications/85143379850 | es_PE |
| dc.rights | info:eu-repo/semantics/openAccess | es_PE |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | es_PE |
| dc.subject | antibiotic | es_PE |
| dc.subject | associated factors (source: MESH) | es_PE |
| dc.subject | COVID-19 | es_PE |
| dc.subject | drug therapy | es_PE |
| dc.subject | ivermectin | es_PE |
| dc.subject | SARS-CoV-2 | es_PE |
| dc.title | Factors Associated with Drug Consumption Without Scientific Evidence in Patients with Mild COVID-19 in Peru. | es_PE |
| dc.type | info:eu-repo/semantics/article | es_PE |
| dc.type.version | info:eu-repo/semantics/publishedVersion | es_PE |
| dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.03.05 | es_PE |
| dc.identifier.doi | https:// doi.org/10.1097/PTS.0000000000001053 | es_PE |







